Pharmacokinetics of 2-nitroimidazole Hypoxic Cell Radiosensitizers in Rodent Peripheral Nervous Tissue
- 1 January 1990
- journal article
- research article
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 57 (5) , 971-980
- https://doi.org/10.1080/09553009014551091
Abstract
The concentrations of seven 2-nitroimidazoles-including misonidazole, etanidazole (SR-2508), pimonidazole (Ro 03-8799), desmethylmisonidazole (Ro 05-9963), RK28, RP170, and KU2285- were measured in the sciatic nerves of C3H/He mice using reverse-phase high-performance liquid chromatography. Drug exposure to the peripheral nervous system was highest for misonidazole, followed by desmethylmisonidazole, etanidazole, pimonidazole and RK28. The lower drug exposure of pimonidazole and RK28 seemed to be related to their lower hydrophilicity. The apparent biological half-lives of the compounds in the peripheral nerves were correlated to their hydrophilicity: the more hydrophilic the compound, the longer the apparent biological half-life in the peripheral nervous tissue of the mice. Measurement of drug exposure in the rodent peripheral nervous system, rather than in the brain, was a better indicator for estimating the occurrence of clinical peripheral neuropathy by 2-nitroimidazoles.This publication has 17 references indexed in Scilit:
- A New, Potent 2-Nitroimidazole Nucleoside Hypoxic Cell Radiosensitizer, RP170Japanese Journal of Cancer Research, 1989
- The Blood-Nerve Barrier and the Pathologic Significance of Nerve EdemaPublished by Springer Nature ,1989
- Phase I trial of the hypoxic cell radiosensitizer SR-2508: The results of the five to six week drug scheduleInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Hypoxic cell radiosensitizers: Expectations and progress in drug developmentInternational Journal of Radiation Oncology*Biology*Physics, 1985
- A phase I study of the hypoxic cell radiosensitizer Ro-03-8799International Journal of Radiation Oncology*Biology*Physics, 1984
- Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508International Journal of Radiation Oncology*Biology*Physics, 1984
- Clinical trials of radiosensitizers: What should we expect?International Journal of Radiation Oncology*Biology*Physics, 1984
- Clinical perspectives for the use of new hypoxic cell sensitizersInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Misonidazole—A drug for trial in radiotherapy and oncologyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- A New Substituent Constant, π, Derived from Partition CoefficientsJournal of the American Chemical Society, 1964